Contents
- Meeting Information
- Registration
- Call for Abstracts
- Program and Abstract
- Abstract Acceptance
- Contact us
Meeting Information
[Name]
The 124th Annual Meeting of the Japanese Dermatological Association
[Dates]
May 29(Thu.) – June 1(Sun.), 2025
[Venue]
Pacifico Yokohama
1-1-1 MinatoMirai, Nishi-ku, Yokohama 220-0012, Japan
[Committee Members]
- President: Akira Ishiko, M.D., Ph.D.
- Department of Dermatology, Faculty of Medicine, Toho University
- Secretary General: Keiji Tanese, M.D., Ph.D.
Registration
Registration fees are as follows
On-the-day registration is not available, so please complete your online registration in advance before attending the meeting.
- Oral and poster presenters at OPiE are not required to register for participation.
However, this does not apply to individuals residing in Japan.
| JDA Member | JPY 20,000 |
|---|---|
| Japanese Student/ Overseas Student/Resident* |
JPY 15,000 |
| Non-Member (Company member) | JPY 40,000 |
| Non-Member (Others) | JPY 25,000 |
| Accompanying Person** | JPY 3,000 |
- Students and Residents need to submit their identification.
- Students including undergraduates and postgraduates are requested to submit a proof of their status such as a photocopy of a valid student ID card or a letter from the dean, the department head or the research director with their signature.
- The Accompanying Persons' registration fee is available only to partners and/or family members of paid delegates registered to attend the Conference. It covers the only admission for Social Gathering. Accompanying person cannot access to a lecture room and Corporate Exhibition venue.
Call for Abstracts
Submission period
From Friday, November 1, 2024 to Tuesday, December 3, 2024 (tentative)
Online abstract submission is now closed.
Tuesday, December 17, 2024 (tentative)
Abstract Submission Procedures
- All abstracts must be submitted through the online abstract submission system.
- Please see the following guidelines before proceeding to the abstract submission page. Click the button at the end of this page to submit.
- For those who have difficulty accessing the online submission system on this website, please contact the secretariat office.
Requirements for Abstract Submission
Only one paper can be presented by the same author and/or presenter, although a presenter can be a coauthor of other papers.
[Encore abstract]
JDA annual meeting will not accept the abstract with exact same title and contents published before in other meetings and articles. JDA has this policy to avoid double publication as a fraud.
If you add a new data or information on the previous reports, we would consider to accept the abstract.
Guidelines for Writing Abstracts
[Presentation style] ※Tentative
We prepare sessions of "Oral Presentations in English" in our meeting on May 29, 2025. You can select your presentation style either of "Oral and Poster" or "Poster Only". The Local Organizing Committee will review the abstracts and decide their final presentation styles ("Oral and Poster presentation" or "Poster Only presentation").
If your abstract accepted as an oral and poster-presentation, you are kindly requested to present it orally on May 29, 2025 and also discussion it as a poster on May 29, PM (Odd poster number) or May 30, PM (Even poster number).
Presenters are required to come to the venue (Yokohama, Japan) and give their oral
and / or poster presentation. There will be no online presentations.
And, presenters are required to prepare both paper poster and digital poster.
If your abstract is not accepted as an oral presentation, you can present it poster only.
Poster discussion is open-ended and speakers should stand-by in front of the poster at the poster discussion time.
And poster presenters are requested to prepare their paper poster and digital poster.(same data)
[Category]
Please choose from the following categories:
- Basic research
- Diagnosis
- Treatment
- Dermatopathology
- Dermatologic surgery
- Inflammatory disease
- Allergic disease
- Autoimmune disease
- Tumor
- Congenital disease
- Infectious disease
- Others
[Abstract Publication]
Your abstract will be published in the meeting program and abstract book.
Online Abstract Submission
Abstract Submission
- Depending on the computer environment, there may be cases where the registrant is unable to register from the meeting web page. (e.g. Firewall is set to prevent intrusion) Please confirm your internet environment in advance.
- It is mandatory that the registrant has an e-mail address that can be made through to him/her.
- An e-mail will be generated automatically to inform the registrant that the abstract is registered. Please be extra careful not to mistype your e-mail address.
*If you do not receive the e-mail, the following may be the cause:
A. You can confirm your abstract from the "Confirmation & Correction" page.
- The e-mail address input was incorrect: Submission has successfully concluded. To avoid duplicated submission, do not submit more than twice. Please confirm and modify the e-mail address from the Confirmation & Correction page.
B. You cannot confirm your abstract from the "Confirmation & Correction" page.
- The submission process did not finish properly: Please submit again.
*Please do not use Gmail.
Please note that those who have registered Gmail address may not receive emails from the abstract submission system.
- Compatible browsers are Safari version 2.0.3 (417.9.2) or above, Firefox, Microsoft Edge and Google Chrome. Do not use other browsers.
Before Submission
- Registered data will be published on the abstract book. There will be no proofreading by the secretariat office. Please be extra careful not to mistype your abstract.
- Change in abstract, including coauthor information, will not be accepted after the deadline. Please confirm thoroughly before submission.
Password
Before you finish your registration, you are required to enter password. Password is case sensitive and must be 4 or more characters long. Do not use passwords used for hospital information systems and e-mails.
Data Entries
<Entering symbols, Greek Letters and other special characters>
Symbols and Greek Letters must be entered using the respective codes from the list of "Abstract Body" on the Registration site. (You may cut and paste from the list.)
Follow the instructions below for special characters. These are also available on the Registration site for you to cut and paste.
- Superscripts: <SUP></SUP>
Example: Na<SUP>+</SUP>=Na+ - Subscripts: <SUB></SUB>
Example: H<SUB>2</SUB>O=H2O - Italics: <I></I>
Example: <I>c-fos</I>=c-fos - Bold: <B></B>
Example: <B>AAA</B>=AAA - Underline: <U></U>
Example: <U>BBB</U>=BBB - If you wish to use "<" (less than) or ">" (greater than) in your abstract (e.g. p<0.05), to distinguish special character codes "< > "explained above from single uses of "<" or ">", enter ">" for ">" and "<" for "<".
Example: p<0.05=p<0.05
Complete Registration
Please confirm the contents you have input before clicking the "Confirm to submit" button.
After submission, registration number (number in the 30000s) will be automatically generated. With the registration number being generated, the abstract submission process is concluded. You will receive a confirmation mail from the system. If you do not see your registration number in the web page, please be aware that the abstract has not been accepted yet.
Please note that the secretariat office will not answer any questions related to the passwords for security purposes.
Should you have any queries on the online registration system, please contact the secretariat office.
Correction
For adding correction to registered abstracts, use the "Confirmation and Correction" button. Before the due date, confirmation and correction can be made repeatedly by inputting the registration number and password.
Abstract Submission Procedures
Submission Periods
From Friday, November 1, 2024 to Tuesday, December 3, 2024 (tentative)
Online abstract submission is now closed.
Tuesday, December 17, 2024 (tentative)
- The system will automatically close after the above date. Corrections, registrations and deleting of the abstracts will not be allowed after the deadline.
Click "Abstract Submission" button when submitting your abstract for the first time.
- Abstract Submission
- Confirmation & Correction
[Restrictions]
- Only abstracts submitted through the online abstract submission system will be considered.
- Abstracts must be submitted in clear English with accurate grammar and spelling.
- Please note that abstracts will be published as submitted, so please check carefully all names as well as spelling and grammar.
Abstract title must be 90 letters or less, including spaces.
Abstract body must be 800 letters or less, including spaces.
Up to 10 coauthors, including authors, and up to 10 affiliations may be registered.
Evaluation
All abstracts will be reviewed and presentation styles (oral and poster presentation or poster presentation only) will be decided by the Local Organizing Committee.
Notification of Accepted Abstracts
First authors will be informed of the decision of the evaluation at the address given for correspondence by early February, 2025. At that time, you will be given full details of your presentation.
Travel grants available (For the participants on site only)
A limited number of travel grants will be awarded by the Local Organizing Committee for applicants, whose abstracts have been evaluated as outstanding. The travel grant provides assistance for transportation costs, but it does not cover the full amount.
Authors wishing to be considered for a travel grant should complete the abstract submission. The nominee must be first author (i.e. presenting author) of an abstract submitted, and should provide proof of their student's or training status with a certificate of the University resp. Head of Department via abstract submission system.
How to submit certificates for travel grant applications
When submitting your abstract, you will find a travel grant application section within the system.
After selecting "Apply," you will be able to upload images. At that time, please register a proof of your student or trainee status with a certificate of the University resp. Head of Department.
You can log in to the system to make changes or modify your application after you have submitted the abstract, as long as it is within the submission period (Tuesday, December 3, 2024).
Program and Abstract
Under construction
Abstract Acceptance
Please check your presentation style.
If your abstract has "conflict of interest (COI)", please mention it at the beginning of your presentation and specify at your poster.
For more information, please check the heading of "Presenter's Instruction" that is scheduled to be released on this website at a later date.
Oral Presentations
The time schedule is very tight. Please keep the allotted time strictly.
5 minutes for presentation and 2 minutes for discussion.
We will inform the oral presenters how to prepare your oral presentation data soon.
Posters Presentations
*All accepted abstracts need to prepare both the paper poster and the digital poster prior to the meeting.
*All posters must be prepared in English.
[Digital poster Registration Period]
From Tuesday, April 15, 2025 to noon Wednesday, May 14, 2025.(tentative)
All of the registered poster data will be freely viewable only for JDA member and participants available for your iPads (by app).
They can check the presentation data only during meeting. (From May 29 to June 1, 2025)
Please make sure to register your poster data in advance to the congress.
[Paper poster requirements]
- Posters should be posted on the designated board space of 180cm height and 90cm width with the abstract number of your paper.
- Title, Author's name, Affiliation should be prepared by yourself.
- Poster mounting and removal hours are as follows:
Mount posters:
May 29(Thu.) 8:00-13:00
Remove posters:
June 1(Sun.)13:30-16:00
*Posters should be up all the time during the congress. - The poster venue is located at Pacifico Yokohama, 1F Exhibition Hall A/B.
- Abstract Numbers, pins and equipment necessary for mounting posters will be prepared by the secretariat at the venue.
- Poster discussion is open-ended. Speakers should stand by in front of the poster at the poster discussion time.
Abstract - Odd numbers
May 29(Thu.) 16:00-17:30(tentative)
Abstract - Even numbers
May 30(Fri.) 18:30-19:30(tentative) *Please check by the last digit of the poster number.
e.g. EP1-1 → odd, EP1-2 → even.
| Submission Number | Poster Number | Oral Number | Date of Oral Presentation | Time of Oral Presentation | Session Number of Oral Presentation | Category of Poster |
|---|---|---|---|---|---|---|
| 10001 | EP10-1 | E3-7 | May 29 (Thu.) | 12:30-13:30 | Oral Presentation in English 3 | Congenital disease |
| 10002 | EP1-1 | Basic research | ||||
| 10006 | EP9-1 | Tumor | ||||
| 10025 | EP7-1 | Allergic disease | ||||
| 10030 | EP12-1 | Others | ||||
| 10044 | EP6-1 | E2-7 | May 29 (Thu.) | 10:00-11:00 | Oral Presentation in English 2 | Inflammatory disease |
| 10061 | EP6-2 | Inflammatory disease | ||||
| 10071 | EP2-1 | E1-3 | May 29 (Thu.) | 9:00-10:00 | Oral Presentation in English 1 | Diagnosis |
| 10101 | EP8-1 | Autoimmune disease | ||||
| 10102 | EP1-2 | Basic research | ||||
| 10108 | EP10-2 | E3-8 | May 29 (Thu.) | 12:30-13:30 | Oral Presentation in English 3 | Congenital disease |
| 10114 | EP7-2 | Allergic disease | ||||
| 10130 | EP9-2 | Tumor | ||||
| 10131 | EP6-3 | Inflammatory disease | ||||
| 10139 | EP8-2 | E3-6 | May 29 (Thu.) | 12:30-13:30 | Oral Presentation in English 3 | Autoimmune disease |
| 10152 | EP12-2 | E4-8 | May 29 (Thu.) | 13:30-14:30 | Oral Presentation in English 4 | Others |
| 10156 | EP11-1 | Infectious disease | ||||
| 10158 | EP4-1 | E2-2 | May 29 (Thu.) | 10:00-11:00 | Oral Presentation in English 2 | Dermatopathology |
| 10180 | EP12-3 | Others | ||||
| 10182 | EP3-1 | E1-8 | May 29 (Thu.) | 9:00-10:00 | Oral Presentation in English 1 | Treatment |
| 10194 | EP5-1 | E2-4 | May 29 (Thu.) | 10:00-11:00 | Oral Presentation in English 2 | Dermatologic surgery |
| 10225 | EP5-2 | E2-5 | May 29 (Thu.) | 10:00-11:00 | Oral Presentation in English 2 | Dermatologic surgery |
| 10267 | EP1-3 | Basic research | ||||
| 10276 | EP9-3 | E4-1 | May 29 (Thu.) | 13:30-14:30 | Oral Presentation in English 4 | Tumor |
| 10286 | EP7-3 | E3-1 | May 29 (Thu.) | 12:30-13:30 | Oral Presentation in English 3 | Allergic disease |
| 10289 | EP8-3 | E3-4 | May 29 (Thu.) | 12:30-13:30 | Oral Presentation in English 3 | Autoimmune disease |
| 10294 | EP11-2 | Infectious disease | ||||
| 10306 | EP8-4 | E3-3 | May 29 (Thu.) | 12:30-13:30 | Oral Presentation in English 3 | Autoimmune disease |
| 10352 | EP5-3 | Dermatologic surgery | ||||
| 10355 | EP4-2 | Dermatopathology | ||||
| 10363 | EP3-2 | Treatment | ||||
| 10383 | EP9-4 | E4-2 | May 29 (Thu.) | 13:30-14:30 | Oral Presentation in English 4 | Tumor |
| 10394 | EP10-3 | Congenital disease | ||||
| 10396 | EP8-5 | Autoimmune disease | ||||
| 10409 | EP10-4 | Congenital disease | ||||
| 10423 | EP7-4 | Allergic disease | ||||
| 30001 | EP11-3 | Infectious disease | ||||
| 30002 | EP7-5 | Allergic disease | ||||
| 30003 | EP2-2 | Diagnosis | ||||
| 30004 | EP8-6 | E3-5 | May 29 (Thu.) | 12:30-13:30 | Oral Presentation in English 3 | Autoimmune disease |
| 30005 | EP11-4 | Infectious disease | ||||
| 30006 | EP6-4 | E2-6 | May 29 (Thu.) | 10:00-11:00 | Oral Presentation in English 2 | Inflammatory disease |
| 30007 | EP9-5 | Tumor | ||||
| 30008 | EP6-5 | Inflammatory disease | ||||
| 30009 | EP8-7 | Autoimmune disease | ||||
| 30010 | EP9-6 | Tumor | ||||
| 30011 | EP6-6 | Inflammatory disease | ||||
| 30012 | EP9-7 | E4-6 | May 29 (Thu.) | 13:30-14:30 | Oral Presentation in English 4 | Tumor |
| 30013 | EP6-7 | Inflammatory disease | ||||
| 30014 | EP7-6 | E3-2 | May 29 (Thu.) | 12:30-13:30 | Oral Presentation in English 3 | Allergic disease |
| 30015 | EP10-5 | Congenital disease | ||||
| 30016 | EP7-7 | Allergic disease | ||||
| 30017 | EP5-4 | Dermatologic surgery | ||||
| 30018 | EP12-4 | Others | ||||
| 30019 | EP10-6 | Congenital disease | ||||
| 30020 | EP6-8 | Inflammatory disease | ||||
| 30021 | EP6-9 | Inflammatory disease | ||||
| 30023 | EP3-3 | E1-5 | May 29 (Thu.) | 9:00-10:00 | Oral Presentation in English 1 | Treatment |
| 30024 | EP6-10 | E2-8 | May 29 (Thu.) | 10:00-11:00 | Oral Presentation in English 2 | Inflammatory disease |
| 30025 | EP3-4 | Treatment | ||||
| 30026 | EP4-3 | E2-1 | May 29 (Thu.) | 10:00-11:00 | Oral Presentation in English 2 | Dermatopathology |
| 30027 | EP2-3 | E1-4 | May 29 (Thu.) | 9:00-10:00 | Oral Presentation in English 1 | Diagnosis |
| 30028 | EP11-5 | E4-7 | May 29 (Thu.) | 13:30-14:30 | Oral Presentation in English 4 | Infectious disease |
| 30029 | EP11-6 | Infectious disease | ||||
| 30030 | EP1-4 | E1-1 | May 29 (Thu.) | 9:00-10:00 | Oral Presentation in English 1 | Basic research |
| 30031 | EP1-5 | Basic research | ||||
| 30032 | EP2-4 | Diagnosis | ||||
| 30034 | EP9-8 | E4-3 | May 29 (Thu.) | 13:30-14:30 | Oral Presentation in English 4 | Tumor |
| 30035 | EP1-6 | Basic research | ||||
| 30036 | EP3-5 | E1-6 | May 29 (Thu.) | 9:00-10:00 | Oral Presentation in English 1 | Treatment |
| 30037 | EP1-7 | Basic research | ||||
| 30038 | EP3-6 | E1-7 | May 29 (Thu.) | 9:00-10:00 | Oral Presentation in English 1 | Treatment |
| 30039 | EP6-11 | Inflammatory disease | ||||
| 30040 | EP12-5 | Others | ||||
| 30041 | EP9-9 | Tumor | ||||
| 30042 | EP5-5 | E2-3 | May 29 (Thu.) | 10:00-11:00 | Oral Presentation in English 2 | Dermatologic surgery |
| 30043 | EP10-7 | Congenital disease | ||||
| 30044 | EP9-10 | E4-4 | May 29 (Thu.) | 13:30-14:30 | Oral Presentation in English 4 | Tumor |
| 30045 | EP10-8 | Congenital disease | ||||
| 30046 | EP6-12 | Inflammatory disease | ||||
| 30048 | EP8-8 | Autoimmune disease | ||||
| 30049 | EP2-5 | E1-2 | May 29 (Thu.) | 9:00-10:00 | Oral Presentation in English 1 | Diagnosis |
| 30050 | EP1-8 | Basic research | ||||
| 30051 | EP9-11 | E4-5 | May 29 (Thu.) | 13:30-14:30 | Oral Presentation in English 4 | Tumor |
| 30052 | EP8-9 | Autoimmune disease | ||||
| No Data | ||||||
Contact us
Secretariat Office of
The 124th Annual Meeting of the Japanese Dermatological Association
c/o The Japanese Dermatological Association
FAX : +81-3-3812-6790
E-mail : jda2025@dermatol.or.jp